technology

1. Name Dr.R.A.Hajare
Designation Ex - R&D Dept. as a Officer, Aarti Drugs Ltd.
Date of Birth 12/12/1979
Department API_ AMD
Email Address rahulhajare@rediffmail.com [9765704048]
Educational Qualification:
Degree Year Institute/University Grade
Post Doc 2015 National AIDS Research Institute Remarkable Achieved
Ph.D 2012 Vinayaka Mission University Achieved
M.Pharm[Quality Assurance] 2005 Nagpur University Distinction
B.Pharm[Pharmaceutical Science] 2002 Amravati University Second
I began my research career from National AIDS Research Institute (ICMR), Pune.
Area of Interest:
My determination and sense of responsibility. My qualification, Behavioural objective and skills and
Innovation. I fit in Scientist.
Awards and Honors:
Post Doc National AIDS Research Institute Pune 2015
American Chemical Society USA 2015
American Association of Pharmaceutical Scientists 2014
Centenary Post Doc fellowship Indian Council of Medical Research (ICMR), India 2013
Sanman Shikshan Vikas Mandal Dabha 2013
Sanman BSPM B.Pharmacy College Ambajogai 2012
Research Experience:
Ex - R & D Dept. as a Officer
Aarti Drugs Ltd - Tarapur Mumbai
May 2016 – September 2016 (5 months) Mumbai Area, India
Job Profile: I was working on API Project, Technology Development, Impurity Identification, AMD
HPLC, UPLC, and Gas Chromatography and UV spectroscopy.
Post Doc.
National AIDS Research Institute Pune
July 2013- March 2015 (1 Year 9 Months) Pune Area India
Job Profile: HIV drug technology, Innovation, Quality assurance technology.

2. ICMR Post Doc Fellow
Indian Council of Medical Research New Delhi
July 2013-March 2015 (1 Year 9 Month) New Delhi
Job Profile: Technology by parallel synthesizer major was used for the purposes of Invention.
Centre for Doctoral Study (Ph. D)
KLE College of Pharmacy Bangalore
September 2006- July 2012 (5 Years 11 Month)
Job Profile: We report here two novels anticancer target compounds 5-Flouro-1-benzyl isatin -2, 3-b
quinoxaline and 5 -Methyl-1-benzyl isatin -2,3-b- quinoxaline and Microwave-assisted organic
synthesis.
Research Scholar
Vinayaka Mission University Salem
September 2006- January 2012 (5 Year 5 Month) Salem
Job Profile: Hetero-cyclic chemistry began and laboratory work admitted
M.Pharm Scholar
Institute of Pharmaceutical Education and Research Nagpur University
August 2003- September 2005 (2 Years 2 Months)
Job Profile: HPLC, Capillary Gas chromatography PerkinElmer microprocessor with BP 624 (volatile)
column for residual solvent analysis. UV-Vis, FT-IR.
Lab Staff
Ana Laboratory- Andheri Mumbai
October 2004 – March 2005 (6 months)
Job Profile: Validation and estimation of organic volatile impurities. Agilent technologies Gas
Chromatography. Head space Gas Chromatography. AMD Validation water HPLC.

3. Assistant Chemist
Link Chem - Pharma Ltd-Vadodara
January 2003 – April 2003 (4 months) Gujarat, India
Job Profile Maintained accurate records, including laboratory notebooks, for site and regulatory
compliance. Properly receive and understand guidance of principal Investigators to plan, coordinate,
and execute R&D projects. Assist in writing and updating laboratory protocols and methods Primary
techniques include: HPLC, UV-Vis. Able to work with minimum supervision (self-starter).
Publication: 54
1. Rahul Anandrao Hajare, Smita S.Kulkarni, Ramesh Shivram Paranjape, Design Space
Filling Model, Synthesis and Evaluation of Novel 2-Indolinone HIV-1 Inhibitors.
International Journal of Advanced Research. (2015), Volume 3, Issue 12, 1332 – 1335.IF:4.5
2. Rahul Hajare, Smita Kulkarni, Madhuri Thakar and Ramesh Paranjape Technology
Development and Design of Novel 1, 3, 5-tri Substituted-1H-Indole-2, 3-Dione HIV-1
Inhibitors With Displays Strategic Nanomolar Cytotoxicity. Volume 5, Issue 6, 391-
397.Impact Factor 6.041
3. Rahul Hajare, Smita Kulkarni, Madhuri Thakar and Ramesh Paranjape Isatin Anti-HIV
Agent: A Review Volume 5, Issue 7, 569-575. Impact Factor 6.041
4. Rahul H, Smita K, Madhuri T, Ramesh P. Variability interaction between Etravirine and
Rilpivirine: a Retrospective Volume 2, Issue 1 – KJACT-100103
5. Rahul Hajare,Ramesh Paranjape,Smita Kulkarni, Technology development and design of
novel 1, 3, 5-tri substituted-1H-indole-2, 3-dione: HIV-1 Inhibitors with displays
strategic nanomolar cytotoxicity. 251st
ACS National Meeting & Exposition held on March
13-17, 2016 in San Diego, CA
6. Rahul Hajare, Ramesh Paranjape, Smita Kulkarni, Tailored microwave technology for
Synthesis N'-[(3Z)-5-chloro-1-(morpholin-4-ylmethyl)-2-oxo-1,2-dihydro-3H-indol-3-
ylidene]pyridine-4 carbohydrazide as HIV-1 inhibitors. Drug Formulation &
Bioavailability Congress" September 05-07, 2016 Beijing, China.
7. Satish Polshettiwar, Chetana Patil, Ajinkya Battuwar, and Rahul Hajare. Formulation and
Evaluation of Sintered Matrix Tablets of Caffiene and its Comparison Over Unsintered
Matrix Tablets. Indo American Journal of Pharmaceutical Research. March 2016. IF:3.04
8. Satish Polshettiwar, Chetana Patil, Ajinkya Battuwar, and Rahul Hajare. Formulation and
Evaluation of Gastroretentive Drug Delivery System of Carevedilol Phosphate by
Sintering Technology. World Journal of Pharmacy and Pharmaceutical Sciences , March 2016.
IF:6.04
9. Rahul Hajare and Subhas Karki, Characterization of novel 2-indolinone derivatives as
anticancer and cytotoxic activity. World Journal of Pharmacy and Pharmaceutical Sciences.
2016-Vol 5,Jan Issue 1, 1995-1002.IF:6.04

4. 10. Dr. R.A. Hajare, A.D. Chavhan. Docking Studies and Synthesis of N-Mannich Bases of
Isatin Derivatives and their Biological Activity. World Journal of Pharmacy and Pharmaceutical
Sciences Volume 3, Issue 2, January 2014. 1825-1839. IF:6.04
11. R.A Hajare and P.P. Chinchole. Similarity of Structure and Analgesic-Anti-Inflammatory
Activity of the Novel Isatin Analogue. International Journal of Chemistry and
Pharmaceutical Sciences 2013, Vol.1 (3): 208-214. IF: 2.117
12. R.A. Hajare and S.A.Polshettiwar. Synthesis and Anti-Convulsant activity of some
different Schiffs and Mannich bases of 5-substituted-1H Indole-2,3 diones. International
Journal of Chemistry and Pharmaceutical Sciences 2013, Vol.1 (3): 199-207. IF: 2.117
13. R. A. Hajare. Molecular Modeling and Drug Development. The Pharma Review. March –
April 2013 V.T.Chamle, P.S.Misal, S.G.Shep, Dr. R.A. Hajare. A Potential Natural gum as
a polymer used in NDDS: Recent investigations. International. Journal of Current Trends in
Pharmaceutical Research 2013, Vol. 1(1): 67-73. IF: 4.402
14. V.T. Chamle, Dr. R.A. Hajare. Passionflower (Passiflora incarnata): Herbal Remedies.
International Journal of Pharmacy and Natural Medicines.2013, Vol.1 (1): 40-43. IF: 1.008
15. S.G. Shep, V.T. Chamle , P.S. Misal, Dr. R.A. Hajare. Floating gastro-retentive dosage
forms-A Novel Approach. International Journal of Research in Pharmacy and Life
Sciences.2013, Vol. 1(1): 59-63. IF: 2.976
16. R.A.Hajare, A.G.Tated. Onion Juice an Effective home remedy for Combating Alopecia.
International Journal of Pharmaceutical Research and Development. January 2013, 93-97.IF
2.01
17. R.A.Hajare. Pharmacological study of the pulmonary cytotoxin 4-ipomeanol on lung
cancer patient. The Clinical Research Plus. Delhi May 2011 PP 24-25.
18. R.A. Hajare, D. W. Wargantiwar, A.V.Chandewar. Docking Studies in Drug Design and
Discovery. The Pharma Review, May – June 2011.
19. R.A. Hajare, S.T.Landge, V. M. Darvhekar A.V.Chandewar. Pharmacophore in drug design
and discovery. The Pharma Review Jan –Feb ( 2011), pp 145-146.
20. R.A Hajare , R.M. Gaurkhede, P.P.Chinchole, A.V.Chandewar, Recent advancement in
developing anti-bacterial, anti-fungal activity in relation to n-methylation and schiff’s
bases of novel indole derivative. The Indian Pharmacist, February, 2011 PP 88-92.
21. Rahul Hajare, Subhas Karki, Synthesis and antımıcrobıal activity of some- 3-substıtuted-2-
oxındole derivatives. Turkish Journal of Pharmaceutical Sciences 8(2), Jan (2011) pp 169-
178.
22. Rahul Hajare1, Vaibhav. Darvhekar, Ashish Shewale, Vijay Patil, Evaluation of
Antihistaminic Activity of Piper Betel Leaf in Guinea Pig. The African Journal of
Pharmacy and Pharmacology.Vol.5 (2), February (2011) pp. 113-117 (African Academic
Journal). IF:0.99
23. R.S.Wagh, R.A.Hajare, A.G.Tated, P.A.Gadbail, F.A.Khan, S.G.Kayal. Method
Development and Validation for Simultaneous Determination of Ebastine and

5. Phenylephirine hydrochloride in Tablet Formulation by RP-HPLC. International Journal
of Pharmaceutical Research and Development. September 2011, 214-220. IF 2.01
24. Ashutosh D. Thakur, Rahul A. Hajare , Revankumar D. Nikhade , Anil V. Chandewar.
Simultaneous Estimation of Tramadol Hydrochloride and Chlorzoxazone by
Absorbance Correction Method. Journal of Pharmacy Research 2011,4(6),1683-1684
25. R.A. Hajare, L.R. Gandhi, A.V.Chandewar. Impurity Designation in Pharmaceutical
Sciences. The Pharma Review. March - April 2011.
26. R. A. Hajare, D. W. Wargantiwar, A. V. Chandewar. Docking Studies in Drug Design and
Discovery. The Pharma Review, May - June 2011.
27. R.A. Hajare, S.T. Landge, V. M. Darvhekar, A.V.Chandewar. Pharmacophore in Drug
Design and Discovery. The Pharma Review. January - February 2011.
28. Hajare R.A., Bombaywala M, Bakde B.V., Channawar M.A., Gawande S.R., Kitukale
M.Chandewar A.V. Nanotechnology- in HIV/AIDS Therapy. International Journal of Pharma
Research and Development. (2010) 003, pp 1-4.
29. R. A. Hajare, S. A. Bajad , A. V. Chandewar, A. D. Thakur. Synthesis, Antimicrobial
Activity and Pharmacophore Development of Nitrogen Containing Heterocyclic
Compounds with Co-ordination Mode of Novel Schiff and Mannich Bases. International
journal of synthesis and characterization July –Dec.2010, 3(2), pp67-76. (Turkey).
30. R. A. Hajare, P. A. Raut, A. Meshram, A. V. Chandewar. Insulin Chewing Gum: A Modern
Era of Drug Delivery. The Pharma Review. AUG (2010), pp 77-79
31. R.A. Hajare, A.Meshram, P.A.Raut, A.D.Chavan, S.A.Bajad, N.A.Chandekar,
A.V.Chandewar. Insulin Chewing Gum can Help Tackle Diabetes Epidemic: Track to
Develop.Journal OF GMP and Industrial Pharmacy. February (2010) pp 42-43.
32. R.A. Hajare, K.S. Parwani, S.A. Bajad, N.A.Chandekar, A.V.Chandewar. Breast cancer and
Indole -3-carbinol: Controversy of estrogen level and enzyme Elastase. Research Journal
of Pharmacy and Technology (2009) pp 439-440.
33. R.A.Hajare, R.M.Gaurkhede P.P. Chinchole, A.V. Chandewar, A.S.Wandhare, S.S.Karki.
Synthesis, structure and spectral characterization of Friedal craft n-benzylation of isatin
and their novel schiff’s base. Asian Journal of Research in Chemistry. (2009) Vol. 2 Issues
3, July- Sept. pp 289-291.
34. Rahul Hajare, Subhas S. Karki, Sujeet Kumar, Vivek S. Bhadauria, Jan Balzarini, Erik De
Clercq. Synthesis, anticancer and cytostatic activity of some 6H-indolo [2, 3-b]
quinoxalines. Acta Pharm. (Croatia) (2009) (59) pp 431–440.
35. Hajare R A, Bakde B V, Chandewar A V. Nutritional attributes of edible mushrooms.
Antiseptic 2009, 106(1), 20-22.
36. R.A. Hajare, S.A. Bajad, K.S. Parwani, N.A.Chandekar, A.V.Chandewar. Therapeutic
Potential of Curcumin in Prostate Cancer. The Pharma Review . November 2009.
37. R.A.Hajare, R.M. Gaurkhede, P.P.Chınchole,S.V. Deshmane, A.V.Chandewar, S.S.Karkı
Validation of gas chromatographic System for estimation of organic volatile impurities

6. in hydro-alcoholic formulation. International Journal of Chemical Sciences. (2008) pp 689
708.
38. R.A.Hajare,R.M. Gaurkhede, P.P. Chınchole, S.V.Deshmane, A.V.Chandewar, S.S.Karkı,
Development and validation of gas chromatographic method for estimation of organic
volatile impurities in some Ayurvedic preparation. Asian Journal of Chemistry. (2008)
pp 6993-6998.
Communicated Paper
1. Characterization of inconsistent unspecified impurity who have associated with specified
impurity and adjacent to other detected impurity in pharmaceuticals
2. Classical technology can run away impurity in pharmaceuticals.
3. Tertiary care in impurity trends.
4. Important, unique bioreactor technology can reduce the CO2 emission. A Modern Era in
Pharma Industry
5. pre_DR technology
6. E- IPA - Encyclopaedia of Impurity profile (IP) for Pharmaceuticals and API
7. Isatin: New Monograph
8. Tailored microwave technology for Synthesis N'-[(3Z)-5-chloro-1-(morpholin-4-ylmethyl)-2
oxo-1,2-dihydro-3H-indol-3-ylidene]pyridine-4-carbohydrazide as HIV-1 inhibitors
9. New production Technology of Diethyl Methyl Phosphate for HIV drug intermediate
10. MALDI-TOF: A Modern Era of IP
11. Monograph Enrofloxacin
12. Waste water treatment
13. Standards of Behaviour, Skill and Psyche can Tackle HIV Epidemic. A Modern Era of Drug
Delivery
14. Response to a Dolutegravir-based regimen in an HIV- infected young adult with disorganized
schizophrenia having multiple comorbidities: A case study
Professional activities
American Chemical Society ACS. Washington, DC
American Association of Pharmaceutical Scientists AAPS. USA
ACS Insight Lab Member American Chemical Society
Society Ethnopharmacology
Intellectual Property Right Government of India Ministry of Commerce and Industry Department of
Industrial Policy and Promotion, Intellectual Property Training Institute, Nagpur
Member Society Ethnopharmacology
Developments projects
1. Indian Council of Medical Research, Government of India, New Delhi in 2013 [ 14,82,000]
2. Savitribai Phule Pune University in 2015 [5,60,000]
3. Savitribai Phule Pune University in 2015 [1,90,000]
4. Pacific University [PhD Project]
5. Intramural Project and Extramural R& D Project

7. 6. Non R& D project Self Finance on dreaded disease
7. Additional collaborative projects
8. Business Development
9. Additional projects finds LinkedIn profile and ResearchGate